Warning letter
Pro Numb Tattoo Numbing Spray, LLC: warning letter of Apr 14, 2026
FDA warning letter 722589 · Center for Drug Evaluation and Research (CDER)
Key facts
| Reference number | 722589 |
|---|---|
| Company | Pro Numb Tattoo Numbing Spray, LLC |
| Subject | CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated |
| Issue date | Apr 14, 2026 |
| Posted date | Apr 21, 2026 |
| Issuing office | Center for Drug Evaluation and Research (CDER) |
| Product type | Drugs |
| CFR sections cited | 211.22, 211.100(a), 211.25(a), 211.166(a), 211.34, 211.68(a), 211.188, 211.165(a), 211.142, 201.128, 211.84(d)(1) |
| Inspection city | Palm Bay |
| Inspection ZIP | 32905-2727 |
| Inspection start date | Nov 5, 2025 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: